Related Experiment Videos
Oocyte donation: insights into implantation
M Moomjy1, I Cholst, R Mangieri
1Center For Reproductive Medicine and Infertility, Department of Obstetrics and Gynecology, The New York Hospital-Cornell Medical Center, New York 10021, USA. mmoomjy@mail.med.cornell.edu
Fertility and Sterility
|February 6, 1999
Summary
Donor oocyte recipients benefit from understanding factors affecting implantation. Tubal disease negatively impacts implantation and delivery rates, necessitating further research for targeted therapies in infertility treatment.
Area of Science:
- Reproductive Medicine
- Infertility Research
- Oocyte Donation
Background:
- Donor oocyte recipients undergo fresh embryo transfer in hormone replacement cycles.
- Understanding factors influencing implantation and delivery is crucial for successful outcomes.
Purpose of the Study:
- To determine if obstetric, gynecologic, or congenital variables impact implantation efficiency or delivery in donor oocyte recipients.
Main Methods:
- Clinical study involving 370 recipients undergoing fresh embryo transfer.
- Regression analyses assessed pregnancy, delivery, miscarriage, and implantation rates.
- Controlled for recipient age in all analyses.
Main Results:
- Achieved a 58.9% clinical pregnancy rate and 30% implantation rate.
- Increasing recipient age significantly decreased implantation rates.
- History of tubal disease and Asherman's syndrome negatively affected implantation and delivery rates.
Conclusions:
- Recipient age and tubal disease history are key factors influencing donor oocyte recipient outcomes.
- Most other uterine factors studied did not significantly affect implantation potential.
- Further research into the negative impact of tubal disease is needed for directed therapies.